A Phase IV HIV PrEP study reveals limited ex vivo potency of oral Maraviroc against HIV-1J. Tiraboschi,J. Fox,C. Herrera,N. Olejniczak,A. Jackson,M. Boffito,L. Else,S. Khoo,D. Back,R. ShattockHIV MEDICINE(2015)引用 0|浏览15暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要